124 related articles for article (PubMed ID: 1325832)
1. Effects of lobenzarit on murine acute viral myocarditis.
Yokoyama T; Kanda T; Suzuki T; Murata K
Cardiovasc Drugs Ther; 1992 Aug; 6(4):403-7. PubMed ID: 1325832
[TBL] [Abstract][Full Text] [Related]
2. The effects of lobenzarit disodium, a novel immunomodulator, upon murine coxsackievirus B3 myocarditis.
Takada H; Kishimoto C; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Heart Vessels; 1993; 8(2):59-66. PubMed ID: 8390975
[TBL] [Abstract][Full Text] [Related]
3. Immunologic identification of lymphocyte subsets in experimental murine myocarditis with encephalomyocarditis virus. Different kinetics of lymphocyte subsets between the heart and the peripheral blood, and significance of Thy 1.2+ (pan T) and Lyt 1+, 23+ (immature T) subsets in the development of myocarditis.
Kishimoto C; Kuribayashi K; Fukuma K; Masuda T; Tomioka N; Abelmann WH; Kawai C
Circ Res; 1987 Nov; 61(5):715-25. PubMed ID: 2889539
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of coxsackievirus B3 myocarditis in mice by lobenzarit disodium through inhibition of splenic pan T cells.
Kishimoto C; Takada H; Kuroki Y; Matsushita I; Hiraoka Y; Kurokawa M; Ochiai H; Sasayama S
Cardiovasc Res; 1993 Feb; 27(2):243-8. PubMed ID: 8386064
[TBL] [Abstract][Full Text] [Related]
5. Viral myocarditis: immunopathogenesis and the effect of immunosuppressive treatment in a murine model.
Matsumori A; Tomioka N; Kawai C
Jpn Circ J; 1989 Jan; 53(1):58-60. PubMed ID: 2541264
[TBL] [Abstract][Full Text] [Related]
6. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice.
Kishimoto C; Kuribayashi K; Masuda T; Tomioka N; Kawai C
Circulation; 1985 Jun; 71(6):1247-54. PubMed ID: 2986878
[TBL] [Abstract][Full Text] [Related]
7. The effect of cyclosporine on the immunopathogenesis of viral myocarditis in mice.
Matoba Y; Matsumori A; Okada I; Ohkusa T; Kawai C
Jpn Circ J; 1991 Apr; 55(4):407-16. PubMed ID: 1646340
[TBL] [Abstract][Full Text] [Related]
8. Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus.
Yokoyama T; Kanda T; Suzuki T; Murata K
Cardiovasc Drugs Ther; 1991 Apr; 5(2):471-80. PubMed ID: 1713056
[TBL] [Abstract][Full Text] [Related]
9. [Immunological background of patients with dilated cardiomyopathy and myocarditis: clinical and experimental studies].
Kishimoto C; Matsumori A; Tomioka N; Sakurai T; Kawai C
J Cardiogr Suppl; 1986; (9):19-25. PubMed ID: 3020133
[TBL] [Abstract][Full Text] [Related]
10. Encephalomyocarditis (EMC) virus myocarditis in DBA/2 mice. I. Acute stage.
Matsumori A; Kawai C; Sawada S
Jpn Circ J; 1981 Dec; 45(12):1403-8. PubMed ID: 6275136
[TBL] [Abstract][Full Text] [Related]
11. An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice.
Matsumori A; Kawai C
Circulation; 1982 Jun; 65(6):1230-5. PubMed ID: 6280889
[TBL] [Abstract][Full Text] [Related]
12. Effect of immunostimulant therapy on acute viral myocarditis in an animal model.
Sato Y; Maruyama S; Kawai C; Matsumori A
Am Heart J; 1992 Aug; 124(2):428-34. PubMed ID: 1322031
[TBL] [Abstract][Full Text] [Related]
13. Encephalomyocarditis (EMC) virus-induced myocarditis by different virus variants and mouse strains.
Hirasawa K; Han JS; Takeda M; Itagaki S; Doi K
J Vet Med Sci; 1992 Dec; 54(6):1125-9. PubMed ID: 1335759
[TBL] [Abstract][Full Text] [Related]
14. In vivo significance of T cells in the development of Coxsackievirus B3 myocarditis in mice. Immature but antigen-specific T cells aggravate cardiac injury.
Kishimoto C; Abelmann WH
Circ Res; 1990 Sep; 67(3):589-98. PubMed ID: 1697791
[TBL] [Abstract][Full Text] [Related]
15. Mural thrombi in mice with acute viral myocarditis.
Tomioka N; Kishimoto C; Matsumori A; Kawai C
Jpn Circ J; 1985 Dec; 49(12):1277-9. PubMed ID: 3007795
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of myocardial injury in myocarditis and cardiomyopathy.
Matsumori A; Okada I; Yamada T; Maruyama S; Kawai C
Jpn Circ J; 1991 Nov; 55(11):1132-7. PubMed ID: 1660942
[TBL] [Abstract][Full Text] [Related]
17. Treatment of viral myocarditis with ribavirin in an animal preparation.
Matsumori A; Wang H; Abelmann WH; Crumpacker CS
Circulation; 1985 Apr; 71(4):834-9. PubMed ID: 2982522
[TBL] [Abstract][Full Text] [Related]
18. Role of interferon in the protective effect of an immunomodulator derived from the Su strain of Streptococcus pyogenes A3 against viral myocarditis in mice.
Kanda T; Yokoyama T; Suzuki T; Murata K
Arzneimittelforschung; 1993 Jan; 43(1):80-3. PubMed ID: 7680562
[TBL] [Abstract][Full Text] [Related]
19. Lessons from animal experiments in myocarditis.
Matsumori A
Herz; 1992 Apr; 17(2):107-11. PubMed ID: 1349548
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulating agents for the management of heart failure with myocarditis and cardiomyopathy--lessons from animal experiments.
Matsumori A; Sasayama S
Eur Heart J; 1995 Dec; 16 Suppl O():140-3. PubMed ID: 8682082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
